These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35304223)

  • 1. Enhancing autophagy in Alzheimer's disease through drug repositioning.
    Eshraghi M; Ahmadi M; Afshar S; Lorzadeh S; Adlimoghaddam A; Rezvani Jalal N; West R; Dastghaib S; Igder S; Torshizi SRN; Mahmoodzadeh A; Mokarram P; Madrakian T; Albensi BC; Łos MJ; Ghavami S; Pecic S
    Pharmacol Ther; 2022 Sep; 237():108171. PubMed ID: 35304223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.
    Mansour HM; Fawzy HM; El-Khatib AS; Khattab MM
    Neuroscience; 2021 Aug; 469():191-196. PubMed ID: 34139302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.
    Jojo GM; Kuppusamy G
    J Clin Pharm Ther; 2019 Jun; 44(3):337-348. PubMed ID: 30738020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlocking the concealed targets using system biology mapping for Alzheimer's disease.
    Joshi P; Kawade V; Dhulap S; Goel M
    Pharmacol Rep; 2019 Dec; 71(6):1104-1107. PubMed ID: 31634797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Antihypertensive Drugs for the Management of Alzheimer's Disease.
    Law CSW; Yeong KY
    Curr Med Chem; 2021; 28(9):1716-1730. PubMed ID: 32164502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering new treatments for Alzheimer's disease by repurposing approved medications.
    Appleby BS; Cummings JL
    Curr Top Med Chem; 2013; 13(18):2306-27. PubMed ID: 24059463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
    Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
    Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug Repositioning for Alzheimer's Disease].
    Ihara M; Saito S
    Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer's Disease.
    Chyr J; Gong H; Zhou X
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia.
    Eshraghi M; Adlimoghaddam A; Mahmoodzadeh A; Sharifzad F; Yasavoli-Sharahi H; Lorzadeh S; Albensi BC; Ghavami S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease.
    Ouyang Q; Meng Y; Zhou W; Tong J; Cheng Z; Zhu Q
    J Drug Target; 2022 Jan; 30(1):61-81. PubMed ID: 33983096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.
    Nguyen TT; Vo TK; Vo GV
    Adv Exp Med Biol; 2021; 1286():183-198. PubMed ID: 33725354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease.
    Mansour HM; Fawzy HM; El-Khatib AS; Khattab MM
    Exp Neurol; 2021 Jul; 341():113697. PubMed ID: 33727095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    Chatterjee P; Roy D; Rathi N
    J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
    Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
    Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.